BPC-157 (Body Protection Compound 157) is a synthetic peptide composed of 15 amino acids, derived from a protein found in human gastric juice
Mechanistic themes seen in preclinical research In animal and mechanistic work, AOD-9604 has been associated with: Increased lipolysis (breaking down stored fat) Reduced lipogenesis (reducing fat storage) Interactions with -adrenergic pathways in adipose tissue have been discussed as part of its lipolytic signaling profile (OUP Academic) In obese animal models, AOD-9604 has shown reductions in body weight and body fat and changes consistent with increased fat mobilization
1 UNIT in a U-40 syringe is 0.025mL
Many labs and buyers rely on manual math when preparing peptide doses, but errors can occur easily
Current research highlights both the strong safety profile and effectiveness of PRP and exosome therapy
If you take antihypertensive medications, your physician should monitor your blood pressure during peptide therapy Anticoagulants and antiplatelet drugs: BPC-157's effects on blood vessel formation and tissue repair could theoretically interact with blood-thinning medications